Seo-Young Lee1,2, Christian Guilleminault3, Hsiao-Yean Chiu1,4, Shannon S Sullivan1. 1. Stanford Outpatient Medical Center, Stanford University Sleep Medicine Division, 450 Broadway Street, Pavilion B 2nd floor, MC 5730, Redwood City, CA, 94063-5730, USA. 2. Kangwon National University College of Medicine, Kanwon-do, Republic of Korea. 3. Stanford Outpatient Medical Center, Stanford University Sleep Medicine Division, 450 Broadway Street, Pavilion B 2nd floor, MC 5730, Redwood City, CA, 94063-5730, USA. cguil@STANFORD.EDU. 4. Graduate Institute of Nursing College of Nursing, Taipei Medical University, Taipei, Taiwan.
Abstract
BACKGROUND: Adenotonsillectomy (T&A) may not completely eliminate sleep-disordered breathing (SDB), and residual SDB can result in progressive worsening of abnormal breathing during sleep. Persistence of mouth breathing post-T&As plays a role in progressive worsening through an increase of upper airway resistance during sleep with secondary impact on orofacial growth. METHODS: Retrospective study on non-overweight and non-syndromic prepubertal children with SDB treated by T&A with pre- and post-surgery clinical and polysomnographic (PSG) evaluations including systematic monitoring of mouth breathing (initial cohort). All children with mouth breathing were then referred for myofunctional treatment (MFT), with clinical follow-up 6 months later and PSG 1 year post-surgery. Only a limited subgroup followed the recommendations to undergo MFT with subsequent PSG (follow-up subgroup). RESULTS: Sixty-four prepubertal children meeting inclusion criteria for the initial cohort were investigated. There was significant symptomatic improvement in all children post-T&A, but 26 children had residual SDB with an AHI > 1.5 events/hour and 35 children (including the previous 26) had evidence of "mouth breathing" during sleep as defined [minimum of 44 % and a maximum of 100 % of total sleep time, mean 69 ± 11 % "mouth breather" subgroup and mean 4 ± 3.9 %, range 0 and 10.3 % "non-mouth breathers"]. Eighteen children (follow-up cohort), all in the "mouth breathing" group, were investigated at 1 year follow-up with only nine having undergone 6 months of MFT. The non- MFT subjects were significantly worse than the MFT-treated cohort. MFT led to normalization of clinical and PSG findings. CONCLUSION: Assessment of mouth breathing during sleep should be systematically performed post-T&A and the persistence of mouth breathing should be treated with MFT.
BACKGROUND: Adenotonsillectomy (T&A) may not completely eliminate sleep-disordered breathing (SDB), and residual SDB can result in progressive worsening of abnormal breathing during sleep. Persistence of mouth breathing post-T&As plays a role in progressive worsening through an increase of upper airway resistance during sleep with secondary impact on orofacial growth. METHODS: Retrospective study on non-overweight and non-syndromic prepubertal children with SDB treated by T&A with pre- and post-surgery clinical and polysomnographic (PSG) evaluations including systematic monitoring of mouth breathing (initial cohort). All children with mouth breathing were then referred for myofunctional treatment (MFT), with clinical follow-up 6 months later and PSG 1 year post-surgery. Only a limited subgroup followed the recommendations to undergo MFT with subsequent PSG (follow-up subgroup). RESULTS: Sixty-four prepubertal children meeting inclusion criteria for the initial cohort were investigated. There was significant symptomatic improvement in all children post-T&A, but 26 children had residual SDB with an AHI > 1.5 events/hour and 35 children (including the previous 26) had evidence of "mouth breathing" during sleep as defined [minimum of 44 % and a maximum of 100 % of total sleep time, mean 69 ± 11 % "mouth breather" subgroup and mean 4 ± 3.9 %, range 0 and 10.3 % "non-mouth breathers"]. Eighteen children (follow-up cohort), all in the "mouth breathing" group, were investigated at 1 year follow-up with only nine having undergone 6 months of MFT. The non- MFT subjects were significantly worse than the MFT-treated cohort. MFT led to normalization of clinical and PSG findings. CONCLUSION: Assessment of mouth breathing during sleep should be systematically performed post-T&A and the persistence of mouth breathing should be treated with MFT.
Authors: Luciana O Palombini; Sergio Tufik; David M Rapoport; Indu A Ayappa; Christian Guilleminault; Luciana B M de Godoy; Laura S Castro; Lia Bittencourt Journal: Sleep Date: 2013-11-01 Impact factor: 5.849
Authors: Christian Guilleminault; Kasey K Li; Andrei Khramtsov; Rafael Pelayo; Sandra Martinez Journal: Laryngoscope Date: 2004-01 Impact factor: 3.325
Authors: Dana C Won; Christian Guilleminault; Peter J Koltai; Stacey D Quo; Martin T Stein; Irene M Loe Journal: J Dev Behav Pediatr Date: 2017 Feb/Mar Impact factor: 2.225
Authors: Christian Guilleminault; Vivien C Abad; Hsiao-Yean Chiu; Brandon Peters; Stacey Quo Journal: Sleep Breath Date: 2015-09-02 Impact factor: 2.816
Authors: Miriam Fioravanti; Francesca Zara; Iole Vozza; Antonella Polimeni; Gian Luca Sfasciotti Journal: Int J Environ Res Public Health Date: 2021-06-06 Impact factor: 3.390